CRSP — CRISPR Therapeutics AG stock price, charts and financials

QT31CRISPR Therapeutics AG

CRISPR Therapeutics AG (NASDAQ: CRSP) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
53.45
-1.33-2.43%
OverviewShort InterestFilings
CRSPQT31CRISPR Therapeutics AG·NASDAQ
53.45-2.43%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 11, 20264Statement of changes in beneficial ownership
Aug 03, 20268-KCurrent report
Aug 03, 202610-QQuarterly report
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 05, 2026S-8Registration of employee benefit securities
Jun 04, 20268-KCurrent report
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 2026SC 13GBeneficial ownership statement (passive)
May 04, 20268-KCurrent report
May 04, 202610-QQuarterly report
#1 / 25 of 346
Page
▼
/ 14